Table 3.
Variable | Odds ratio (95% CI) | P-value |
---|---|---|
Age | 0.86 (0.6 − 1.23) | 0.41 |
Male Gender | 1.12 (0.77 − 1.62) | 0.55 |
Serum albumin at diagnosis (>3.6 g/dL) | 1.57 (1.09 − 2.25) | 0.014 |
Serum bilirubin at diagnosis | 0.41 (0.28 − 0.6) | <0.001 |
AST | 0.64 (0.45 − 0.92) | 0.015 |
Age of diagnosis of UC or CD | 0.55 (0.38 − 0.79) | 0.001 |
Duration of UC or CD prior to PSC diagnosis | 2.92 (1.98 − 4.29) | <0.001 |
Age of diagnosis with PSC | 0.89 (0.62 − 1.27) | 0.52 |
UDCA use | 1.07 (0.69 − 1.63) | 0.77 |
Requirement for OLT | 0.36 (0.24 − 0.53) | <0.001 |
Mayo PSC risk score | 0.51 (0.35 − 0.73) | <0.001 |
5-Aminosalicylate use | 1.15 (0.79 − 1.66) | 0.47 |
Azathioprine/6-mercaptopurine use | 1.99 (1.2 − 3.29) | 0.006 |
Number of disease flares | 4.37 (2.91 − 6.55) | <0.001 |
Presence of dysplasia/cancer | 4.79 (3.33 − 6.88) | <0.001 |
Colon cancer | 5.18 (3.21 − 8.36) | <0.001 |
CD (relative to UC) | 0.6 (0.36 − 1.02) | 0.06 |
AST = aspartate aminotransferase; UC = ulcerative colitis; CD = Crohn’s disease; PSC = primary sclerosing cholangitis; UDCA = ursodexoxycholic acid; OLT = orthotropic liver transplantation